Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 6, 2001
Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
D Rea, M J Havenga, M van Den Assem, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1989
Suppression of cellular gene activity in adenovirus-transformed cells
A J van der Eb, H T Timmers, R Offringa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion
R E Toes, R C Hoeben, E I van der Voort, et al.
Cell
|
August 10, 1990
A novel function of the transforming domain of E1a: repression of AP-1 activity
R Offringa, S Gebel, H van Dam, et al.
European Journal of Immunology
|
February 17, 1998
Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis
J P Medema, R E Toes, C Scaffidi, et al.
Nature Medicine
|
July 8, 1999
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
L Diehl, A T den Boer, S P Schoenberger, et al.
The Journal of Experimental Medicine
|
September 19, 2001
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
R P Sutmuller, L M van Duivenvoorde, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 9, 1998
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
R E Toes, E I van der Voort, S P Schoenberger, et al.
European Journal of Immunology
|
May 6, 1999
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma
M E Ressing, J H de Jong, R M Brandt, et al.
Biochemical Society Transactions
|
August 1, 1995
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape
R E Toes, M C Feltkamp, M E Ressing, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Journal of Immunology (Baltimore, Md. : 1950)
|
April 6, 2001
Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
D Rea, M J Havenga, M van Den Assem, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1989
Suppression of cellular gene activity in adenovirus-transformed cells
A J van der Eb, H T Timmers, R Offringa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion
R E Toes, R C Hoeben, E I van der Voort, et al.
Cell
|
August 10, 1990
A novel function of the transforming domain of E1a: repression of AP-1 activity
R Offringa, S Gebel, H van Dam, et al.
European Journal of Immunology
|
February 17, 1998
Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis
J P Medema, R E Toes, C Scaffidi, et al.
Nature Medicine
|
July 8, 1999
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
L Diehl, A T den Boer, S P Schoenberger, et al.
The Journal of Experimental Medicine
|
September 19, 2001
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
R P Sutmuller, L M van Duivenvoorde, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 9, 1998
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
R E Toes, E I van der Voort, S P Schoenberger, et al.
European Journal of Immunology
|
May 6, 1999
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma
M E Ressing, J H de Jong, R M Brandt, et al.
Biochemical Society Transactions
|
August 1, 1995
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape
R E Toes, M C Feltkamp, M E Ressing, et al.
Page
of 10